Fibroblast activation and inflammation in frozen shoulder

Moeed Akbar, Michael McLean, Emma Garcia-Melchor, Lindsay An Crowe, Paul McMillan, Umberto G Fazzi, David Martin, Angus Arthur, James H Reilly, Iain B McInnes, Neal L Millar, Moeed Akbar, Michael McLean, Emma Garcia-Melchor, Lindsay An Crowe, Paul McMillan, Umberto G Fazzi, David Martin, Angus Arthur, James H Reilly, Iain B McInnes, Neal L Millar

Abstract

Introduction: Frozen shoulder is a common, fibro-proliferative disease characterised by the insidious onset of pain and progressively restricted range of shoulder movement. Despite the prevalence of this disease, there is limited understanding of the molecular mechanisms underpinning the pathogenesis of this debilitating disease. Previous studies have identified increased myofibroblast differentiation and proliferation, immune cell influx and dysregulated cytokine production. We hypothesised that subpopulations within the fibroblast compartment may take on an activated phenotype, thus initiating the inflammatory processes observed in frozen shoulder. Therefore, we sought to evaluate the presence and possible pathogenic role of known stromal activation proteins in Frozen shoulder.

Methods: Shoulder capsule samples were collected from 10 patients with idiopathic frozen shoulder and 10 patients undergoing shoulder stabilisation surgery. Fibroblast activation marker expression (CD248, CD146, VCAM and PDPN, FAP) was quantified using immunohistochemistry. Control and diseased fibroblasts were cultured for in vitro studies from capsule biopsies from instability and frozen shoulder surgeries, respectively. The inflammatory profile and effects of IL-1β upon diseased and control fibroblasts was assessed using ELISA, immunohistochemistry and qPCR.

Results: Immunohistochemistry demonstrated increased expression of fibroblast activation markers CD248, CD146, VCAM and PDPN in the frozen shoulder group compared with control (p < 0.05). Fibroblasts cultured from diseased capsule produced elevated levels of inflammatory protein (IL-6, IL-8 & CCL-20) in comparison to control fibroblasts. Exposing control fibroblasts to an inflammatory stimuli, (IL-1ß) significantly increased stromal activation marker transcript and protein expression (CD248, PDPN and VCAM).

Conclusions: These results show that fibroblasts have an activated phenotype in frozen shoulder and this is associated with inflammatory cytokine dysregulation. Furthermore, it supports the hypothesis that activated fibroblasts may be involved in regulating the inflammatory and fibrotic processes involved in this disease.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Fibroblast activation markers in shoulder…
Fig 1. Fibroblast activation markers in shoulder capsule.
Representative images of and control capsule and frozen shoulder tissue sections stained with Haematoxylin and Eosin (x10 magnification, bar indicates 200μm) and antibodies against CD248, CD146, VCAM, PDPN, CD34, and FAP (x40). Isotype control in bottom right corner (x10 magnification, bar indicates 150μm).
Fig 2. Fibroblast activation marker expression in…
Fig 2. Fibroblast activation marker expression in control capsule and frozen shoulder.
Graphs illustrate Modified Bonar scoring & % of cells positively stained for samples of human capsule biopsies for expression of CD248, CD146, VCAM, PDPN, CD34 and FAP, mean ± SEM, n  =  10 for control capsule, n  =  10 for frozen shoulder capsule. Modified Bonar scoring system depicts mean score per sample based on 10 high power fields. 0  =  no staining, 1  =  20% + ve staining of cells per high power field. *p t-test).
Fig 3. Inflammatory cytokine production from capsule…
Fig 3. Inflammatory cytokine production from capsule derived fibroblasts.
IL-6, CCL20 and IL-8 secretion from healthy capsule and diseased capsule derived fibroblasts, mean ± SEM, n = 5 *p t-test).
Fig 4. Fibroblast activation markers are upregulated…
Fig 4. Fibroblast activation markers are upregulated in shoulder capsule upon inflammatory stimulus and inflammatory protein in healthy fibroblasts following IL-1β (10ng/ml) stimulation.
(a) Stromal activation marker (CD248, PDPN, VCAM & CD146) mRNA expression following IL-1β stimulation of cultured healthy derived fibroblasts. Data represented 2-ΔΔCT, normalized to GAPDH housekeeping control, mean ± SEM, n = 5. *p < 0.05, **p < 0.01 compared to control samples (Students t-test). (b) Representative images of healthy capsule derived fibroblasts following IL-1β stimulation. Cells stained with antibodies against CD248, PDPN, VCAM and CD146, image at x40 magnification (bar is 200μm). Isotype control in bottom left corner (x40).
Fig 5. Activated capsule fibroblasts drive proinflammatory…
Fig 5. Activated capsule fibroblasts drive proinflammatory cytokine production.
IL-6, CCL20 and IL-8 mRNA and protein expression following IL-1β stimulation. mean ± SEM, n = 5, *p t-test).
Fig 6. Immunobiology of frozen shoulder.
Fig 6. Immunobiology of frozen shoulder.
Schematic illustration representing the functional interplay between the “activated” stromal fibroblast (CD248+, CD146+,VCAM+,PDPN+) (stromal compartment), infiltrating and resident immune cells (immune compartment) and downstream cytokine/alarmin dysregulation interacting to drive a proinflammatory phenotype with aberrant tissue fibrosis in the frozen shoulder joint capsule.

References

    1. Zuckerman JD, Rokito A. Frozen shoulder: a consensus definition. Journal of Shoulder and Elbow Surgery. 2011;20(2):322–5. 10.1016/j.jse.2010.07.008
    1. Ryan V, Brown H, Minns Lowe CJ, Lewis JS. The pathophysiology associated with primary (idiopathic) frozen shoulder: A systematic review. BMC Musculoskelet Disord. 2016;17(1):340 Epub 2016/08/17. 10.1186/s12891-016-1190-9
    1. Hand GC, Athanasou NA, Matthews T, Carr AJ. The pathology of frozen shoulder. J Bone Joint Surg Br. 2007;89(7):928–32. 10.1302/0301-620X.89B7.19097 .
    1. Millar NL, Murrell GAC, McInnes IB. Inflammatory mechanisms in tendinopathy—towards translation. Nature reviews Rheumatology. 2017;13(2):110–22. 10.1038/nrrheum.2016.213
    1. Millar NL, Gilchrist DS, Akbar M, Reilly JH, Kerr SC, Campbell AL, et al. MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon disease. Nat Commun. 2015;6:6774 10.1038/ncomms7774
    1. Cher JZB, Akbar M, Kitson S, Crowe LAN, Garcia-Melchor E, Hannah SC, et al. Alarmins in Frozen Shoulder: A Molecular Association Between Inflammation and Pain. Am J Sports Med. 2018;46(3):671–8. Epub 2017/12/01. 10.1177/0363546517741127 .
    1. Hagiwara Y, Ando A, Onoda Y, Takemura T, Minowa T, Hanagata N, et al. Coexistence of fibrotic and chondrogenic process in the capsule of idiopathic frozen shoulders. Osteoarthritis Cartilage. 2012;20(3):241–9. Epub 2012/01/12. 10.1016/j.joca.2011.12.008 .
    1. Bunker TD, Anthony PP. The pathology of frozen shoulder. A Dupuytren-like disease. J Bone Joint Surg Br. 1995;77(5):677–83. .
    1. Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, Salmon M. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 2001;22(4):199–204. .
    1. Buckley CD, Barone F, Nayar S, Benezech C, Caamano J. Stromal cells in chronic inflammation and tertiary lymphoid organ formation. Annu Rev Immunol. 2015;33:715–45. 10.1146/annurev-immunol-032713-120252 .
    1. Millar NL, Murrell GAC, McInnes IB. Alarmins in tendinopathy: unravelling new mechanisms in a common disease. Rheumatology (Oxford). 2012;In Press.
    1. Filer A, Raza K, Salmon M, Buckley CD. The role of chemokines in leucocyte-stromal interactions in rheumatoid arthritis. Frontiers in bioscience: a journal and virtual library. 2008;13:2674–85.
    1. Buckley CD, Gilroy DW, Serhan CN, Stockinger B, Tak PP. The resolution of inflammation. Nat Rev Immunol. 2013;13(1):59–66. 10.1038/nri3362 .
    1. Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer cell. 2006;9(4):261–72. Epub 2006/04/18. 10.1016/j.ccr.2006.03.010 .
    1. Maggi L, Margheri F, Luciani C, Capone M, Rossi MC, Chilla A, et al. Th1-Induced CD106 Expression Mediates Leukocytes Adhesion on Synovial Fibroblasts from Juvenile Idiopathic Arthritis Patients. PLoS One. 2016;11(4):e0154422 Epub 2016/04/29. 10.1371/journal.pone.0154422
    1. Maia M, DeVriese A, Janssens T, Moons M, Lories RJ, Tavernier J, et al. CD248 facilitates tumor growth via its cytoplasmic domain. BMC cancer. 2011;11:162 Epub 2011/05/10. 10.1186/1471-2407-11-162
    1. Elshal MF, Khan SS, Takahashi Y, Solomon MA, McCoy JP Jr. CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. Blood. 2005;106(8):2923–4. Epub 2005/10/06. 10.1182/blood-2005-06-2307 .
    1. Dakin SG, Buckley CD, Al-Mossawi MH, Hedley R, Martinez FO, Wheway K, et al. Persistent stromal fibroblast activation is present in chronic tendinopathy. Arthritis Res Ther. 2017;19(1):16 10.1186/s13075-016-1218-4
    1. Hwang KR, Murrell GA, Millar NL, Bonar F, Lam P, Walton JR. Advanced glycation end products in idiopathic frozen shoulders. J Shoulder Elbow Surg. 2016;25(6):981–8. 10.1016/j.jse.2015.10.015 .
    1. Millar NL, Hueber AJ, Reilly JH, Xu Y, Fazzi UG, Murrell GA, et al. Inflammation is present in early human tendinopathy. Am J Sports Med. 2010;38(10):2085–91. 10.1177/0363546510372613 .
    1. Millar NL, Wei AQ, Molloy TJ, Bonar F, Murrell GA. Cytokines and apoptosis in supraspinatus tendinopathy. J Bone Joint Surg Br. 2009;91(3):417–24. Epub 2009/03/05. 91-B/3/417 [pii] 10.1302/0301-620X.91B3.21652. 10.1302/0301-620X.91B3.21652 .
    1. Campbell AL, Smith NC, Reilly JH, Kerr SC, Leach WJ, Fazzi UG, et al. IL-21 receptor expression in human tendinopathy. Mediators Inflamm. 2014;2014:481206 10.1155/2014/481206
    1. Hand G, Athanasou N, Matthews T, Carr A. The pathology of frozen shoulder. Bone & Joint Journal. 2007;89(7):928–32.
    1. Bunker T, Reilly J, Baird K, Hamblen D. Expression of growth factors, cytokines and matrix metalloproteinases in frozen shoulder. Bone & Joint Journal. 2000;82(5):768–73.
    1. Rodeo SA, Hannafin JA, Tom J, Warren RF, Wickiewicz TL. Immunolocalization of cytokines and their receptors in adhesive capsulitis of the shoulder. Journal of Orthopaedic Research. 1997;15(3):427–36. 10.1002/jor.1100150316
    1. Lho YM, Ha E, Cho CH, Song KS, Min BW, Bae KC, et al. Inflammatory cytokines are overexpressed in the subacromial bursa of frozen shoulder. J Shoulder Elbow Surg. 2013;22(5):666–72. 10.1016/j.jse.2012.06.014 .
    1. Tchou J, Zhang PJ, Bi Y, Satija C, Marjumdar R, Stephen TL, et al. Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer. Hum Pathol. 2013;44(11):2549–57. Epub 2013/10/01. 10.1016/j.humpath.2013.06.016
    1. Filer A. The fibroblast as a therapeutic target in rheumatoid arthritis. Curr Opin Pharmacol. 2013;13(3):413–9. Epub 2013/04/09. 10.1016/j.coph.2013.02.006 .
    1. Matsuyama T, Kitani A. The role of VCAM-1 molecule in the pathogenesis of rheumatoid synovitis. Hum Cell. 1996;9(3):187–92. Epub 1996/09/01. .
    1. Entezari M, Weiss DJ, Sitapara R, Whittaker L, Wargo MJ, Li J, et al. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis. Mol Med. 2012;18:477–85. Epub 2012/02/09. molmed.2012.00024 [pii] 10.2119/molmed.2012.00024. 10.2119/molmed.2012.00024
    1. Musumeci D, Roviello GN, Montesarchio D. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacol Ther. 2014;141(3):347–57. 10.1016/j.pharmthera.2013.11.001 .
    1. Schiraldi M, Raucci A, Munoz LM, Livoti E, Celona B, Venereau E, et al. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J Exp Med. 2012;209(3):551–63. Epub 2012/03/01. jem.20111739 [pii] 10.1084/jem.20111739
    1. Foell D, Kane D, Bresnihan B, Vogl T, Nacken W, Sorg C, et al. Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford). 2003;42(11):1383–9. 10.1093/rheumatology/keg385 .
    1. Foell D, Roth J. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum. 2004;50(12):3762–71. 10.1002/art.20631 .
    1. Hackett L, Millar NL, Lam P, Murrell GA. Are the Symptoms of Calcific Tendinitis Due to Neoinnervation and/or Neovascularization? J Bone Joint Surg Am. 2016;98(3):186–92. 10.2106/JBJS.O.00417 .

Source: PubMed

3
Abonnieren